Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients

Clinical Nephrology

Volumn 58, Issue 3, 2002, Pages 190-197

  Ikizler, T A ^a   Morrow, J D ^a   Roberts, L J ^a   Evanson, J A ^a   Becker, B ^a   Hakim, R M ^a   Shyr, Y ^a   Himmelfarb, J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Inflammation; Mortality; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ISOPROSTANE DERIVATIVE; PHOSPHOLIPID; BIOMATERIAL;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORTALITY; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICAL SIGNIFICANCE; UREMIA; ARTIFICIAL MEMBRANE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; INSTRUMENTATION; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; RISK FACTOR;

AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; C-REACTIVE PROTEIN; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; F2-ISOPROSTANES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; RENAL DIALYSIS; RISK FACTORS; SMOKING;

EID: 0036707471     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp58190     Document Type: Article

References (28)

1. No direct evidence of increased lipid peroxidation in hemodialysis patients
2. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
3. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?
4. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients
5. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis
6. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomized placebo-controlled trial
7. Increased lipid peroxidation in patients on maintenance hemodialysis
8. Analysis of longitudinal data
9. Cardiac disease in chronic uremia: Clinical outcome and risk factors
10. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
11. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
12. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure
13. Manifestations of oxidant stress in uremia
14. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
15. Unbalanced repeated-measures models with structured covariance matrices
16. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
17. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients
18. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia
19. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism
20. Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome
21. The isoprostanes: Unique prostaglandin-like products of free-radical-initiated lipid peroxidation
22. Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment
23. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
24. Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats
25. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis
26. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis
27. Cardiovascular disease and chronic renal disease: A new paradigm
28. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients